Hiren Patel, MD

  • 5Articles
  • 32.7KReads
  • 2014–2024Active
  • 28Collaborators
  • 42Citations

About

Hiren Patel, MD, affiliated with Penn State Milton S. Hershey Medical Center, has authored multiple articles for Psychiatrist.com from 2014 to 2024. Patel's work focuses on depression, including treatment-resistant forms, addiction, psychiatric comorbidities, and the clinical implications of COVID-19 medications. The author has also explored complementary and alternative medicine as well as psychopharmacology, with publications addressing topics such as ketamine therapies and FDA perspectives on new antidepressants. Frequent collaborators include Zeeshan Mansuri, Bhumika Shah, and Chintan Trivedi.

Publications

PCC
Intravenous Ketamine vs Intranasal Esketamine for TRD
Letter to the Editor

Intravenous Ketamine vs Intranasal Esketamine for TRD

February 13, 2024

Dr Mansuri and colleagues compare the pros and cons of IV ketamine and intranasal esketamine for treatment-resistant depression.
, , , et al
PCC
Psychiatric Comorbidities of Neurofibromatosis
Original Research

Psychiatric Comorbidities of Neurofibromatosis

October 3, 2023

Neurofibromatosis is a group of inherited neurocutaneous disorders that includes neurofibromatosis types 1 and 2 and schwannomatosis. This study assessed the prevalence of psychiatric comorbidities in patients with neurofibromatosis.
, , , et al
PCC
Letter to the Editor

Interactions With IL-6 Inhibitors and Agents for Opioid Use: Drs Mansuri and Colleagues Reply

February 18, 2021

In this letter to the editor, the authors reply to Kow and Hasan.
, , , et al
PCC
Commentary

Opioid Use Disorder Treatment and Interaction With COVID-19 Medication

July 2, 2020

In this commentary, the authors discuss the potential interactions of opioid use disorder treatments with novel COVID-19 medications.
, , , et al
JCP
Perspective

The US Food and Drug Administration's Perspective on the New Antidepressant Vortioxetine

November 11, 2014

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe